AI-powered Digital Patient Twin platform that simulates real patient responses to accelerate clinical trial design.
Infiuss Health's Digital Patient Twin platform (Probe) creates comprehensive virtual representations of patients by integrating medical records, genomics, imaging, labs, and wearables to simulate disease progression and treatment outcomes before clinical trials begin. The platform is HIPAA and GDPR compliant with 256-bit AES encryption, HL7 FHIR support, and 99.9% uptime SLA. It targets clinical researchers, CROs, and healthcare systems looking to reduce study timelines and optimize RCT protocols. Infiuss Health is a product of Infiuss Health.